A Closer Look at Reporting Toxicities in Cancer Clinical Trials

QoL for patients with cancer is reduced just as much by the accumulation of low-level toxicities as it is from high-level adverse events.

from Latest articles from Cancer Therapy Advisor Brain Cancer http://bit.ly/2GcArIK